Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jesus M. Banales, PhD"'
Autor:
Robert Markewitz, MD, Antje Torge, PhD, Klaus-Peter Wandinger, MD, Daniela Pauli, MD, Justina Dargvainiene, Andre Franke, MD, Luis Bujanda, MD, PhD, José Maria Marimón, PharmD, Jesus M. Banales, PhD, María A. Gutierrez-Stampa, MD, PhD, Beatriz Nafría, BSc, Ralf Junker, MD
Publikováno v:
International Journal of Infectious Diseases, Vol 110, Iss , Pp 114-122 (2021)
Abstract:: Objectives: To examine the relationship between antibody status and cycle threshold (Ct) values, the prognostic value of the latter for COVID-19 patients, and the inter-assay comparability of SARS-CoV-2 Ct values. Methods: In 347 COVID-19
Externí odkaz:
https://doaj.org/article/d19d07a29ca649b6aa785dc6db12940e
Autor:
Monika Lewinska, PhD, Alvaro Santos-Laso, PhD, Enara Arretxe, PhD, Cristina Alonso, PhD, Ekaterina Zhuravleva, PhD, Raul Jimenez-Agüero, MD, PhD, Emma Eizaguirre, MD, PhD, María Jesús Pareja, MD, PhD, Manuel Romero-Gómez, MD, PhD, Marco Arrese Jimenez, MD, PhD, Malte P. Suppli, MD, PhD, Filip K. Knop, MD, PhD, Stine Karlsen Oversoe, MD, PhD, Gerda Elisabeth Villadsen, MD, PhD, Thomas Decaens, MD, PhD, Flair Jose Carrilho, MD, PhD, Claudia PMS de Oliveira, MD, PhD, Bruno Sangro, MD, PhD, Rocio I.R. Macias, MD, PhD, Jesus M. Banales, PhD, Jesper B. Andersen, PhD
Publikováno v:
EBioMedicine, Vol 73, Iss , Pp 103661- (2021)
Background: Non-alcoholic fatty liver disease (NAFLD) is affecting more people globally. Indeed, NAFLD is a spectrum of metabolic dysfunctions that can progress to hepatocellular carcinoma (NAFLD-HCC). This development can occur in a non-cirrhotic li
Externí odkaz:
https://doaj.org/article/a98663c5714b4b39a2da1a493b1539b3
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 11, Iss 1, Pp 294-296 (2021)
Externí odkaz:
https://doaj.org/article/6cd83adbf4d9433a8077ab8389ff049c